Intellia Therapeutics Call to Discuss Interim Clinical Data from NTLA-2001 Phase 1 Study February 28, 2022 at 4:30 PM EST Click here for webcast Supporting Materials NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial – June 24, 2022 1 MB
NTLA-2001 for ATTR Amyloidosis: Interim Clinical Results from Ongoing Phase 1 Trial – June 24, 2022 1 MB
